Citations

Showing 10 of 108162 citations.

Clinical practice gap: annual skin cancer screening examinations for visually impaired patients
Ali, Nora S., Villalpando, Beija K. , Roddy, Gavin W. , Sartori‐Valinotti, Julio C.

Mayo Clinic

International Journal of Dermatology | April 19, 2021 | Volume: 60 | Issue: 10 | Pages: No page available

10.1111/ijd.15614 | PMID 33871057 Get It

Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY
Klomjit, Nattawat , Zand, Ladan , Klomjit, Nattawat

Mayo Clinic

Kidney360 | April 19, 2021 | Volume: 2 | Issue: 11 | Pages: 1702-1705

10.34067/kid.0002492021 | PMID 35378023 Get It

Towards a new era with safer µ-opiate receptor analgesia
Camilleri, Michael

Mayo Clinic

Gut | April 19, 2021 | Volume: 71 | Issue: 1 | Pages: 1.2-2

10.1136/gutjnl-2021-324618 | PMID 33875448 Get It

Managing valproic acid toxicity-related hyperammonaemia: an unpredicted course
Pagali, Sandeep R. , Edquist, Christopher , O'Rourke, Nicholas, Pagali, Sandeep , O'Rourke, Nicholas

Mayo Clinic

BMJ Case Reports | April 19, 2021 | Volume: 14 | Issue: 4 | Pages: e241547

10.1136/bcr-2020-241547 | PMID 33875509 Get It

A 20-year-old woman presented following an intentional overdose of valproic acid. Use of valproic acid, either acute or chronic, can result in hyperammonaemia. Mild hyperammonaemia with chronic use is mostly asymptomatic but can also present with concern for encephalopathy. Acute valproic acid toxicity results in significant hyperammonaemia, which can contribute to encephalopathy. Levocarnitine is the treatment of choice in valproic acid toxicity-related hyperammonaemia. For severe cases of encephalopathy, intermittent haemodialysis can also be considered. To our knowledge, this is the first case report to clearly show symptom relapse and hyperammonaemia after discontinuing levocarnitine. We recommend levocarnitine therapy for at least 72 hours, followed by an additional 24 hours of monitoring for symptom relapse and hyperammonaemia after levocarnitine discontinuation.
Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials
Tyler, Jeffrey , Brown, Christopher , Jentzer, Jacob C. , Baran, David A. , Kapur, Navin K. , Garberich, Ross , García, Santiago , Henry, Timothy D. , Tyler, Jeffrey M , Jentzer, Jacob C , Kapur, Navin K , Henry, Timothy D , Baran, David A , Diepen, Sean van , Sharkey, Scott W.

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 19, 2021 | Volume: 99 | Issue: 1 | Pages: 19-26

10.1002/ccd.29710 | PMID 33871159 Get It

AbstractBackgroundAmong acute myocardial infarction patients with cardiogenic shock (AMICS), a number of key variables predict mortality, including cardiac arrest (CA) and shock classification as proposed by Society for Cardiovascular Angiography and Intervention (SCAI). Given this prognostic importance, we examined the frequency of reporting of high risk variables in published randomized controlled trials (RCTs) of AMICS patients.MethodsWe identified 15 RCTs enrolling 2,500 AMICS patients and then reviewed rates of CA, baseline neurologic status, right heart catheterization data, lactate levels, inotrope and vasopressor requirement, hypothermia, mechanical ventilation, left ventricular ejection fraction (LVEF), mechanical circulatory support, and specific cause of death based on the primary manuscript and Data in S1.ResultsA total of 2,500 AMICS patients have been enrolled in 15 clinical trials over 21 years with only four trials enrolling >80 patients. The reporting frequency and range for key prognostic factors was: neurologic status (0% reported), hypothermia (28% reported, prevalence 33–75%), specific cause of death (33% reported), cardiac index and wedge pressure (47% reported, range 1.6–2.3 L min−1 m−2 and 15–24 mmHg), lactate (60% reported, range 4–7.7 mmol/L), LVEF (73% reported, range 25–45%), CA (80% reported, prevalence 0–92%), MCS (80% reported, prevalence 13–100%), and mechanical ventilation (93% reported, prevalence 35–100%). This variability was reflected in the 30‐day mortality which ranged from 20–73%.ConclusionsIn a comprehensive review of seminal RCTs in AMICS, important predictors of outcome were frequently not reported. Future efforts to standardize CS trial data collection and reporting may allow for better assessment of novel therapies for AMICS.
Author response: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
Liao, Lili, Langbein, Lauren , Cho, Eun-Ah , Niu, Xiaohua , Jiang, Wei , Zhong, Zhijiu , Jagannathan, Geetha , Dulaimi, Essel, Testa, Joseph R. , Wang, Yuxin , Stark, George R. , Peiper, Stephen, Yang, Haifeng , Liu, Zongzhi Z. , Cai, Weijia , Na, Jie, Cai, Wesley L. , Uzzo, Robert G. , Sun, Jianxin , Xu, Yaomin , Yan, Qin

Mayo Clinic

No container title available | April 19, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.37925.sa2 Get It

Morphological and Hemodynamic Changes during Cerebral Aneurysm Growth
Nordahl, Emily Rose, Dennis, Kendall D. , Sejkorová, Alena , Hejčl, Aleš , Hron, J. , Švihlová, Helena , Carlson, Kent, Suzen, Yildirim , Dragomir‐Daescu, Dan , Uthamaraj, Susheil , Sejkorová, Alena , Hejčl, Aleš , Hron, Jaroslav , Švihlová, Helena , Carlson, Kent D, Dragomir-Daescu, Dan

Mayo Clinic

Brain Sciences | April 19, 2021 | Volume: 11 | Issue: 4 | Pages: 520

10.3390/brainsci11040520 | PMID 33921861 Get It

Computational fluid dynamics (CFD) has grown as a tool to help understand the hemodynamic properties related to the rupture of cerebral aneurysms. Few of these studies deal specifically with aneurysm growth and most only use a single time instance within the aneurysm growth history. The present retrospective study investigated four patient-specific aneurysms, once at initial diagnosis and then at follow-up, to analyze hemodynamic and morphological changes. Aneurysm geometries were segmented via the medical image processing software Mimics. The geometries were meshed and a computational fluid dynamics (CFD) analysis was performed using ANSYS. Results showed that major geometry bulk growth occurred in areas of low wall shear stress (WSS). Wall shape remodeling near neck impingement regions occurred in areas with large gradients of WSS and oscillatory shear index. This study found that growth occurred in areas where low WSS was accompanied by high velocity gradients between the aneurysm wall and large swirling flow structures. A new finding was that all cases showed an increase in kinetic energy from the first time point to the second, and this change in kinetic energy seems correlated to the change in aneurysm volume.
Correction for Mathison et al., “Medical Parasitology Taxonomy Update, January 2018 to May 2020”
Mathison, Blaine A. , Bradbury, Richard S. , Pritt, Bobbi S. , Pritt, Bobbi S , Mathison, Blaine A

Mayo Clinic

Journal of Clinical Microbiology | April 19, 2021 | Volume: 59 | Issue: 5 | Pages: No page available

10.1128/jcm.00525-21 | PMID 33879563 Get It

Deep-learning-based direct synthesis of low-energy virtual monoenergetic images with multi-energy CT
Gong, Hao , Marsh, Jeffrey F., DSouza, Karen N. , Huber, Nathan R. , D'Souza, Karen N , Rajendran, Kishore , McCollough, Cynthia H , Leng, Shuai , Rajendran, Kishore , Fletcher, Joel G. , McCollough, Cynthia H. , Leng, Shuai

Mayo Clinic

Journal of Medical Imaging | April 19, 2021 | Volume: 8 | Issue: 05 | Pages: No page available

10.1117/1.jmi.8.5.052104 | PMID 33889658 Get It

Peak Systolic Blood Pressure During the Exercise Test: Reference Values by Sex and Age and Association With Mortality
Assaf, Yazan , Barout, Ahmad, Al-Mouakeh, Ahmad , Barillas-Lara, Maria Irene , Fortin-Gamero, Sonia, Bonikowske, Amanda R. , Pepine, Carl J. , Allison, Thomas G. , Allison, Thomas G , Alhamid, Ahmad Abdul Hakim

Mayo Clinic

Hypertension | April 19, 2021 | Volume: 77 | Issue: 6 | Pages: 1906-1914

10.1161/hypertensionaha.120.16570 | PMID 33866799 Get It

We sought to update norms for peak systolic blood pressure (SBP) on the graded exercise test and examine its prognostic value in patients without baseline cardiovascular disease. Mayo graded exercise test data (1993–2010) were reviewed for nonimaging tests using Bruce protocol, selecting Minnesota residents 30 to 79 years without baseline cardiovascular disease. We formed a pure cohort of patients without factors significantly affecting peak SBP to determine peak SBP percentile norms by age and sex. Then we divided the full cohort of patients into 5 groups based on peak SBP percentiles: low (<10th), borderline low (10th–25th), referent (25th–75th), borderline high (75th–90th), and high (>90th). The relationship between peak SBP and mortality was tested using Cox regression adjusting for age, sex, and comorbidities affecting peak SBP or mortality. We identified 20 760 eligible patients with 7313 females (35%) and mean age 51.5±10.7 years. Our pure cohort included 7810 patients. Over 12.5±5.0 years follow-up, there were 1582 deaths, including 541 cardiovascular deaths. In the fully adjusted model, low-peak SBP was associated with increased total mortality (heart rate, 1.41 [1.19–1.66], P <0.0001) and cardiovascular mortality (heart rate, 1.54 [1.16–2.03], P =0.001), while borderline low-peak SBP was associated with increased cardiovascular mortality only (heart rate, 1.36 [1.02–1.81], P =0.027). High peak SBP was associated with increased total mortality only in the age-sex adjusted model (heart rate, 1.18 [1.02–1.36], P =0.026), not after full adjustment. We conclude that low exercise peak SBP is an independent predictor of higher total and cardiovascular mortality.